Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup
2020 · Cancers · 48 citations
https://doi.org/10.3390/cancers12051308
J
Jolijn W. Groeneweg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
447
Citations
10
h-index
10
i10-index
Jolijn W. Groeneweg is an academic researcher from Heidelberg University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 10, co-authored 48 publications.
ORCID: 0000-0002-8259-8434Papers by this author
worksDual HER2 Targeting Impedes Growth of <i>HER2</i> Gene–Amplified Uterine Serous Carcinoma Xenografts
2014 · Clinical Cancer Research · 41 citations
https://doi.org/10.1158/1078-0432.ccr-14-1647
HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant
2015 · Gynecologic Oncology · 37 citations
https://doi.org/10.1016/j.ygyno.2015.01.533
Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model
2014 · Gynecologic Oncology · 17 citations
https://doi.org/10.1016/j.ygyno.2014.03.560
Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?
2025 · Journal of Ovarian Research · 7 citations
https://doi.org/10.1186/s13048-025-01622-5
Robot-assisted laparoscopic debulking surgery for recurrent adult granulosa cell tumors
2021 · Gynecologic Oncology Reports · 4 citations
https://doi.org/10.1016/j.gore.2021.100783
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat